We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+34.98%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$376M
AUM Growth
-$31.2M
Cap. Flow
-$73.1M
Cap. Flow %
-19.42%
Top 10 Hldgs %
14.32%
Holding
275
New
96
Increased
11
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
BLU
BELLUS Health Inc.
BLU
+$6.2M
2
PI icon
Impinj
PI
+$5.08M
3
HLIT icon
Harmonic Inc
HLIT
+$4.59M
4
EXTR icon
Extreme Networks
EXTR
+$3.71M
5
PLMR icon
Palomar
PLMR
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 33.5%
2 Technology 16%
3 Industrials 11.73%
4 Energy 11.68%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBC icon
101
RBC Bearings
RBC
$17.6B
$1.73M 0.46%
+8,307
New +$1.91M
MODN
102
DELISTED
MODEL N, INC.
MODN
$1.71M 0.46%
+50,007
New +$1.45M
RVNC
103
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.71M 0.45%
+63,279
New +$1.28M
TA
104
DELISTED
TravelCenters of America LLC
TA
$1.71M 0.45%
+31,682
New +$1.58M
AXSM icon
105
Axsome Therapeutics
AXSM
$11.4B
$1.71M 0.45%
38,218
UFPT icon
106
UFP Technologies
UFPT
$2.48B
$1.7M 0.45%
19,752
LUCK
107
Lucky Strike Entertainment
LUCK
$893M
$1.69M 0.45%
+137,131
New +$1.64M
FC icon
108
Franklin Covey
FC
$243M
$1.68M 0.45%
+37,095
New +$1.84M
CRK icon
109
Comstock Resources
CRK
$4.25B
$1.68M 0.45%
96,996
+11,865
+14% +$196K
POSH
110
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$1.67M 0.44%
+106,559
New +$1.27M
GTHX
111
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.66M 0.44%
+133,203
New +$1.52M
SNEX icon
112
StoneX
SNEX
$7.69B
$1.66M 0.44%
101,321
-37,564
-27% -$643K
KDNY
113
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.66M 0.44%
84,346
MRTN icon
114
Marten Transport
MRTN
$1.2B
$1.66M 0.44%
+86,415
New +$1.73M
DXLG icon
115
Destination XL Group
DXLG
$33.2M
$1.66M 0.44%
+305,390
New +$1.46M
ASO icon
116
Academy Sports + Outdoors
ASO
$3.05B
$1.64M 0.44%
+38,905
New +$1.7M
NVEE
117
DELISTED
NV5 Global
NVEE
$1.64M 0.43%
+52,832
New +$1.73M
TH icon
118
Target Hospitality
TH
$1.65B
$1.62M 0.43%
128,236
-154,691
-55% -$1.94M
CALM icon
119
Cal-Maine
CALM
$3.86B
$1.62M 0.43%
+29,069
New +$1.59M
VRDN icon
120
Viridian Therapeutics
VRDN
$2.61B
$1.62M 0.43%
+78,810
New +$1.42M
PHR icon
121
Phreesia
PHR
$766M
$1.61M 0.43%
+63,320
New +$1.58M
BELFB
122
Bel Fuse Inc Class B
BELFB
$4.18B
$1.6M 0.43%
+63,571
New +$1.49M
VERU icon
123
Veru
VERU
$43.2M
$1.6M 0.43%
13,908
-15,907
-53% -$2.29M
DBI icon
124
Designer Brands
DBI
$334M
$1.59M 0.42%
+104,139
New +$1.63M
EZPW icon
125
Ezcorp Inc
EZPW
$1.68B
$1.59M 0.42%
+206,740
New +$1.71M

Similar funds

EAM Global Investors's Q3 2022 Portfolio in Review

As of Q3 2022, EAM Global Investors held 275 positions worth $376M, down 7.7% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

EAM Global Investors withdrew a net $73.1M in Q3 2022, closing 103 positions and reducing 42 holdings. Its most notable exit was FLEX LNG, an estimated $7.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in BELLUS Health Inc. worth $6.19M.

  • EAM Global Investors's largest Q3 2022 buy was BELLUS Health Inc.: 583,593 shares worth $6.19M.
  • EAM Global Investors added most to e.l.f. Beauty in Q3 2022, an estimated $2.46M increase.
  • EAM Global Investors's biggest Q3 2022 reduction was BancFirst, cutting an estimated $2.31M.
  • EAM Global Investors fully exited FLEX LNG in Q3 2022, selling an estimated $7.59M.
  • EAM Global Investors's ten largest holdings make up 14% of its $376M portfolio in Q3 2022.
  • EAM Global Investors opened 96 new positions and closed 103 in Q3 2022.
  • EAM Global Investors's portfolio value fell 7.7% quarter-over-quarter to $376M.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.